Koers ICON PLC Irish S.E.
Aandelen
ICLR
IE0005711209
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 8,64 mld. 7,95 mld. | Omzet 2025 * | 9,28 mld. 8,54 mld. | Marktkapitalisatie | 26,02 mld. 23,95 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 820 mln. 755 mln. | Nettowinst (verlies) 2025 * | 1 mld. 920 mln. | EV/omzet 2024 * | 3,28 x |
Nettoschuld 2024 * | 2,29 mld. 2,11 mld. | Nettoschuld 2025 * | 1,13 mld. 1,04 mld. | EV/omzet 2025 * | 2,93 x |
K/w-verhouding 2024 * |
31,8
x | K/w-verhouding 2025 * |
26,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,35% |
Recentste transcriptie over ICON PLC
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Cutler
CEO | Chief Executive Officer | 63 | 01-11-11 |
Brendan Brennan
DFI | Director of Finance/CFO | 45 | 01-01-06 |
Ciaran Murray
CHM | Chairman | 61 | 03-10-05 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Climax
FOU | Founder | 71 | 01-06-90 |
Stephen Cutler
CEO | Chief Executive Officer | 63 | 01-11-11 |
Linda Grais
BRD | Director/Board Member | 68 | 01-07-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,63% | 50,85 mld. | |
-0,09% | 42,82 mld. | |
+49,62% | 42,03 mld. | |
-4,96% | 29,55 mld. | |
-21,95% | 19,13 mld. | |
+8,61% | 13,05 mld. | |
+28,31% | 12,16 mld. | |
+24,73% | 12,08 mld. | |
-6,26% | 11,58 mld. |